An updated review in Current Gastroenterology Reports (July 2016, Carroll and Benedetti) walks the complications and management ladder of short bowel syndrome - from diet and antisecretory drugs to growth factors - and places teduglutide as the enteral-trophic option for patients still dependent on IV nutrition.
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.